Bicycle Therapeutics plc (BCYC) has a consensus analyst rating of Buy, based on 21 analysts covering the stock. Of those, 17 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for BCYC is $11.00, representing a +117.4% upside from the current price of $5.06. Price targets range from a low of $8.00 to a high of $13.00.
